Correlation of cCD20 level with clinical parameters in patients with CLL
| Variable . | p (r value) . |
|---|---|
| Hemoglobin level | .02 (−0.18)* |
| β2-microglobulin level | .006 (0.23)* |
| RAI: 0, I-II, III-IV | .01† |
| Binet: A, B, C | .004† |
| Platelet count | .004 (−0.22)* |
| CD19+/CD38+, % | .03 (0.20)* |
| Splenomegaly | .07‡ |
| Hepatomegaly | .25‡ |
| Node enlargement | .11‡ |
| Age | .53 (0.05)* |
| Lymphocyte count | .71 (−0.03)* |
| White blood cell count | .33 (−0.07)* |
| Sex | .66‡ |
| Variable . | p (r value) . |
|---|---|
| Hemoglobin level | .02 (−0.18)* |
| β2-microglobulin level | .006 (0.23)* |
| RAI: 0, I-II, III-IV | .01† |
| Binet: A, B, C | .004† |
| Platelet count | .004 (−0.22)* |
| CD19+/CD38+, % | .03 (0.20)* |
| Splenomegaly | .07‡ |
| Hepatomegaly | .25‡ |
| Node enlargement | .11‡ |
| Age | .53 (0.05)* |
| Lymphocyte count | .71 (−0.03)* |
| White blood cell count | .33 (−0.07)* |
| Sex | .66‡ |